Christopher David Snook
Direktor/Vorstandsmitglied bei Sandoz Pharmaceuticals AG
Profil
Christopher David Snook is currently a Director at Sandoz Pharmaceuticals AG and Alcon Canada, Inc. He was previously a Director and Head-Investor Relations at Pennant International Group Plc from 2000 to 2017.
Aktive Positionen von Christopher David Snook
| Unternehmen | Position | Beginn |
|---|---|---|
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Direktor/Vorstandsmitglied | - |
Alcon Canada, Inc.
 Alcon Canada, Inc. Electronic ComponentsElectronic Technology Alcon Canada, Inc. engages in developing, manufacturing, and marketing eye care products and instrumentation. Its products include alcon surgical, alcon pharmaceutical and alcon vision care products. The company is headquartered in Mississauga, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Christopher David Snook
| Unternehmen | Position | Ende |
|---|---|---|
| PENNANT INTERNATIONAL GROUP PLC | Vorstandsvorsitzender | 21.02.2017 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PENNANT INTERNATIONAL GROUP PLC | Technology Services |
| Private Unternehmen | 2 |
|---|---|
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Health Technology |
Alcon Canada, Inc.
Alcon Canada, Inc. Electronic ComponentsElectronic Technology Alcon Canada, Inc. engages in developing, manufacturing, and marketing eye care products and instrumentation. Its products include alcon surgical, alcon pharmaceutical and alcon vision care products. The company is headquartered in Mississauga, Canada. | Electronic Technology |
